Cargando…
Covid-19 and Mucormycosis Superinfection: Prospective, Obsevational Study in a Single Center
BACKGROUND: Mucormycosis (MCR) has been increasingly described in patients with coronavirus disease 2019 (COVID-19), but the epidemiological factors, neurological presentation, and outcome of such patients are not well described. AIMS: To study the patient demographics, presenting symptoms and signs...
Autores principales: | Garg, Shubham, Masheshwari, Dilip, Bhushan, Bharat, Sardana, Vijay, Jain, Raj Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350760/ https://www.ncbi.nlm.nih.gov/pubmed/35936631 http://dx.doi.org/10.4103/aian.aian_1097_21 |
Ejemplares similares
-
COVID-19 and mucormycosis superinfection: the perfect storm
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2021) -
COVID-19 and mucormycosis superinfection: Exploring the missing pathophysiological links
por: Almas, Talal, et al.
Publicado: (2021) -
SUPERINFECTIONS IN PATIENTS INFECTED WITH COVID-19: A SINGLE-CENTER EXPERIENCE
por: Kewan, Tariq, et al.
Publicado: (2020) -
COVID‐19‐associated facial cutaneous mucormycosis superinfection: A potentially life‐threatening disease
por: Zareshahrabadi, Zahra, et al.
Publicado: (2022) -
Role of Surgical Procedures (VP Shunt and ETV) in Tuberculous Meningitis with Hydrocephalus (TBMH): A Systematic Review
por: Bhushan, Bharat, et al.
Publicado: (2021)